FDA action counts
| Total FDA actions | 1 |
|---|---|
| Warning letters | 0 |
| Recalls | 1 |
| Approval records | 0 |
| Form 483 inspection citations | 0 |
| Most recent action | June 10, 2026 |
Enforcement history
On 2026-06-10, Argus HQ recorded an FDA recall for KAYSERBETTEN GMBH & CO. KG, rated "critical" severity in Argus HQ's classification: KAYSERBETTEN GMBH & CO. KG — Class I recall: Pediatric care bed; Product Designation: KayserBett IDA;. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.
Risk pattern analysis
Argus HQ analysis — not an FDA finding
This section is Argus HQ analysis, not an FDA finding. KAYSERBETTEN GMBH & CO. KG has 1 FDA event on file. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
Frequently asked questions
- How many FDA actions has KAYSERBETTEN GMBH & CO. KG had?
- Argus HQ has recorded 1 FDA events for KAYSERBETTEN GMBH & CO. KG: 0 warning letters, 1 recalls, 0 approvals, and 0 Form 483 inspection observations. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
- What is the most recent FDA action against KAYSERBETTEN GMBH & CO. KG?
- The most recent FDA event Argus HQ has on file for KAYSERBETTEN GMBH & CO. KG is dated 2026-06-10, with a severity rating of "critical" in Argus HQ's classification. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
- Does Argus HQ track new FDA actions for KAYSERBETTEN GMBH & CO. KG automatically?
- Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to KAYSERBETTEN GMBH & CO. KG is observed, this page's event count and history update automatically.
- How many FDA actions does Argus HQ track for KAYSERBETTEN GMBH & CO. KG?
- 1 total: 0 warning letters, 1 recall, 0 approval records, and 0 Form 483 inspection citations.
Every FDA action tied to this company, the week it happens.
Free weekly briefing. Real-time alerts on paid plans.
Related enforcement actions
Compare with
Two different companies merged onto this page by mistake? Or a name variant missing? Tell us — corrections@argushq.ai
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Verified from FDA.gov · Last updated: Jun 10, 2026Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). KAYSERBETTEN GMBH & CO. KG's Complete FDA Record. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/company/kayserbetten-gmbh-and-co-kg
"KAYSERBETTEN GMBH & CO. KG's Complete FDA Record." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/company/kayserbetten-gmbh-and-co-kg.
Argus HQ Research. "KAYSERBETTEN GMBH & CO. KG's Complete FDA Record." Digital Empire Holdings LLC. Accessed August 29, 2026. https://argushq.ai/company/kayserbetten-gmbh-and-co-kg.
@misc{argushq_argushq_ai_company_kayserbetten_gmbh_and_co_kg_2026,
title = {KAYSERBETTEN GMBH & CO. KG's Complete FDA Record},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire Holdings LLC},
url = {https://argushq.ai/company/kayserbetten-gmbh-and-co-kg},
note = {Accessed: August 29, 2026}
}Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗